Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2022-04-06
2023-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes
NCT05000021
An Online, Compassion Intervention for Adults with Type 1 and Type 2 Diabetes Mellitus (T1DM; T2DM).
NCT05749029
Improving Mental Health in Diabetes: A Guided Self-Help Study
NCT01473017
Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression
NCT05734313
An Emotion-Focused Intervention for Glycemic Control in T2D
NCT03553680
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
COMPASS
This is a single arm study. We are investigating COMPASS digital CBT.
COMPASS: digital CBT
COMPASS is an evidence based digital CBT intervention with guided therapist support, tailored to treat anxiety and/or depression in long term conditions (LTCs). The intervention consists of eleven modules/sessions in which CBT techniques are taught. Users of COMPASS receive guided therapist support from a trained therapist. The guided support aims to help patients identify and apply the CBT skills outlined in COMPASS to meet their individual needs and experiences of living with LTC(s). The support can occur through in-site messaging or via the telephone.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
COMPASS: digital CBT
COMPASS is an evidence based digital CBT intervention with guided therapist support, tailored to treat anxiety and/or depression in long term conditions (LTCs). The intervention consists of eleven modules/sessions in which CBT techniques are taught. Users of COMPASS receive guided therapist support from a trained therapist. The guided support aims to help patients identify and apply the CBT skills outlined in COMPASS to meet their individual needs and experiences of living with LTC(s). The support can occur through in-site messaging or via the telephone.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with T1 diabetes or T2 diabetes
* Have been self-referred/been referred to Southwark or Hackney (London) IAPT service for psychological support.
* Speak English to a sufficiently high standard to allow them to interact with COMPASS.
* Have access to the internet.
GSTT (Secondary care recruitment)
The same criteria will be applied as above but with the additional criteria in place:
* Have psychological distress levels below the cut offs outlined by the service for face-to-face psychological treatment (see below for criteria):
* (Diabetes Distress Scale (DDS-17) mean score \<4
and/or
\- Patient Health Questionnaire (PHQ-9) score \<19
and/or
\- Generalised Anxiety Disorder Scale (GAD-7 score) \<15
AND
\- Diabetes Eating Problems Scale- Revised (DEPS-R) score \<20)
or
\- Are deemed eligible for digital support by a clinician for patients who have not been assessed using mental health screening tools.
IAPT (primary care recruitment)
Exclusion Criteria
* Evidence of a severe mental health disorder (including bipolar disorder or psychosis) and/or alcohol and/or drug dependency identified by highly trained IAPT therapists as part of routine care.
* Acute suicidal risk requiring a level of support that cannot be provided by therapists who are supporting patients remotely in their use of digital health interventions.
GSTT (secondary care recruitment)
\- Evidence of a diabetes related eating disorder requiring a level of support that cannot be provided by therapists who are supporting patients remotely in their use of digital health interventions evidenced through a DEPS-R score of ≥20.
Eligibility criteria for the qualitative study - Qualitative Patient and healthcare professionals (HCP) interviews:
* The investigators will interview participants who have experience of receiving COMPASS and those who do not uptake COMPASS.
* The investigators also aim to interview participants who commenced COMPASS and subsequently dropped out of treatment.
* The investigators will interview HCPs who have assessed and triaged patients for treatment, and those who have provided psychological support to individuals with diabetes.
* Patients and HCPs will be purposively sampled to achieve a mix of age, gender, ethnicity, clinical variables and/or professional experience.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
South London and Maudsley NHS Foundation Trust
OTHER
King's College London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Guys Hospital
London, Other, United Kingdom
Emma Jenkinson
London, , United Kingdom
King's College London
London, , United Kingdom
South London and Maudsley
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
301444
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.